ctrl K

Price Alert

Verrica Pharmaceuticals I... (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

6.06

-0.10 (-1.62%)

At close: Aug 19, 2025, 3:59 PM

6.12

0.99%

After-hours: Aug 19, 2025, 05:35 PM EDT

Verrica Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.33M	69.55M	34.27M	15.75M
Short-Term Investments	n/a	n/a	n/a	54.6M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	376K	452K	n/a	n/a
Receivables	77K	4.42M	487K	n/a
Inventory	2.46M	1.02M	-487K	n/a
Other Current Assets	2.31M	n/a	487K	n/a
Total Current Assets	51.18M	77.53M	39.12M	74.33M
Property-Plant & Equipment	2.58M	3.62M	5.61M	5.8M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.96M	4.07M	5.61M	5.8M
Total Assets	54.13M	81.6M	44.72M	80.13M
Account Payables	1.9M	2.46M	507K	845K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	12.94M	700K	297K	41.69M
Other Current Liabilities	12.34M	8.34M	1.1M	255K
Total Current Liabilities	29.01M	17.02M	3.46M	46.05M
Long-Term Debt	30.98M	42.87M	n/a	n/a
Other Long-Term Liabilities	2.65M	n/a	n/a	n/a
Total Long-Term Liabilities	34.98M	44.81M	1.23M	1.47M
Total Liabilities	63.99M	61.83M	4.69M	47.52M
Total Debt	45.94M	45.51M	1.53M	43.41M
Common Stock	9K	4K	4K	3K
Retained Earnings	-307.03M	-230.45M	-163.45M	-138.97M
Comprehensive Income	n/a	n/a	n/a	-29K
Shareholders Equity	-9.86M	19.76M	40.03M	32.6M
Total Investments	n/a	n/a	n/a	54.6M